Literature DB >> 24646266

Measurement of glyoxalase activities.

Makoto Arai, Naomi Nihonmatsu-Kikuchi, Masanari Itokawa1, Naila Rabbani2, Paul J Thornalley2.   

Abstract

Glyoxalase I catalyses the isomerization of the hemithioacetal formed non-enzymatically from methylglyoxal and glutathione to S-D-lactoylglutathione. The activity of glyoxalase I is conventionally measured spectrophotometrically by following the increase in A240 for which the change in molar absorption coefficient Δε240=2.86 mM⁻¹·cm⁻¹. The hemithioacetal is pre-formed in situ by incubation of methylglyoxal and glutathione in 50 mM sodium phosphate buffer (pH 6.6) at 37°C for 10 min. The cell extract is then added, the A240 is monitored over 5 min, and the initial rate of increase in A240 and hence glyoxalase I activity deduced with correction for blank. Glyoxalase I activity is given in units per mg of protein or cell number where one unit is the amount of enzyme that catalyses the formation of 1 μmol of S-D-lactoylglutathione per min under assay conditions. Glyoxalase II catalyses the hydrolysis of S-D-lactoylglutathione to D-lactate and glutathione. Glyoxalase II activity is also measured spectrophotometrically by following the decrease in A240 for which the change in molar absorption coefficient Δε240=-3.10 mM⁻¹·cm⁻¹. It is given in units per mg of protein or cell number where one unit is the amount of enzyme that catalyses the hydrolysis of 1 μmol of S-D-lactoylglutathione per min under assay conditions. Glyoxalase I and glyoxalase II activity measurements have been modified for use with a UV-transparent microplate for higher sample throughput.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24646266     DOI: 10.1042/BST20140010

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  25 in total

1.  Metal-Binding Pharmacophore Library Yields the Discovery of a Glyoxalase 1 Inhibitor.

Authors:  Christian Perez; Amanda M Barkley-Levenson; Benjamin L Dick; Peter F Glatt; Yadira Martinez; Dionicio Siegel; Jeremiah D Momper; Abraham A Palmer; Seth M Cohen
Journal:  J Med Chem       Date:  2019-01-31       Impact factor: 7.446

2.  Pentachlorophenol-induced cytotoxicity in human erythrocytes: enhanced generation of ROS and RNS, lowered antioxidant power, inhibition of glucose metabolism, and morphological changes.

Authors:  Nikhil Maheshwari; Fahim Halim Khan; Riaz Mahmood
Journal:  Environ Sci Pollut Res Int       Date:  2019-03-20       Impact factor: 4.223

3.  Featured Article: Pyruvate preserves antiglycation defenses in porcine brain after cardiac arrest.

Authors:  Gary F Scott; Anh Q Nguyen; Brandon H Cherry; Roger A Hollrah; Isabella Salinas; Arthur G Williams; Myoung-Gwi Ryou; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-31

4.  Protective effect of catechin on pentachlorophenol-induced cytotoxicity and genotoxicity in isolated human blood cells.

Authors:  Nikhil Maheshwari; Riaz Mahmood
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-08       Impact factor: 4.223

5.  Nordihydroguaiaretic acid inhibits glyoxalase I, and causes the accumulation of methylglyoxal followed by cell-growth inhibition.

Authors:  Masahiro Watanabe; Takao Toyomura; Ryo Ikegami; Yui Suwaki; Minami Sada; Hidenori Wake; Takashi Nishinaka; Omer Faruk Hatipoglu; Hideo Takahashi; Masahiro Nishibori; Shuji Mori
Journal:  Mol Biol Rep       Date:  2022-09-20       Impact factor: 2.742

6.  Methylglyoxal-Mediated Dopamine Depletion, Working Memory Deficit, and Depression-Like Behavior Are Prevented by a Dopamine/Noradrenaline Reuptake Inhibitor.

Authors:  Gudrian Ricardo Lopes de Almeida; Jozimar Carlos Szczepanik; Ingrid Selhorst; Ariana Ern Schmitz; Bárbara Dos Santos; Maurício Peña Cunha; Isabella Aparecida Heinrich; Gabriela Cristina de Paula; Andreza Fabro De Bem; Rodrigo Bainy Leal; Alcir Luiz Dafre
Journal:  Mol Neurobiol       Date:  2020-10-04       Impact factor: 5.590

7.  Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia.

Authors:  Hana Malinská; Martina Hüttl; Denisa Miklánková; Jaroslava Trnovská; Iveta Zapletalová; Martin Poruba; Irena Marková
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

8.  Combined glyoxalase 1 dysfunction and vitamin B6 deficiency in a schizophrenia model system causes mitochondrial dysfunction in the prefrontal cortex.

Authors:  Kazuya Toriumi; Stefano Berto; Shin Koike; Noriyoshi Usui; Takashi Dan; Kazuhiro Suzuki; Mitsuhiro Miyashita; Yasue Horiuchi; Akane Yoshikawa; Mai Asakura; Kenichiro Nagahama; Hsiao-Chun Lin; Yuki Sugaya; Takaki Watanabe; Masanobu Kano; Yuki Ogasawara; Toshio Miyata; Masanari Itokawa; Genevieve Konopka; Makoto Arai
Journal:  Redox Biol       Date:  2021-06-24       Impact factor: 11.799

9.  Increase in the peripheral blood methylglyoxal levels in 10% of hospitalized chronic schizophrenia patients.

Authors:  Shingo Yoshioka; Hiroko Odani; Tadaaki Furuhashi; Tsutomu Tanaka; Toyoaki Ogawa
Journal:  Nagoya J Med Sci       Date:  2021-02       Impact factor: 1.131

10.  Hemolytic and antimalarial effects of tight-binding glyoxalase 1 inhibitors on the host-parasite unit of erythrocytes infected with Plasmodium falciparum.

Authors:  Cletus A Wezena; Miriam Urscher; Robert Vince; Swati S More; Marcel Deponte
Journal:  Redox Biol       Date:  2016-03-02       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.